PUBLIC COMPANY
saveBoehringer Ingelheim Corp
updated 1mo ago
C.H. Boehringer Sohn AG & Co. KG is the parent company of the Boehringer Ingelheim group, which was founded in 1885 by Albert Boehringer (1861–1939) in Ingelheim am Rhein, Germany. As of 2018, Boehringer Ingelheim is one of the world's largest pharmaceutical companies, and the largest private one.
community read0 votes
pipeline
27
marketed
20
phase 3
0
catalysts ytd
3
approvals ytd
3
recalls ytd
0
Pipeline(27)
view full pipeline →pipeline depth27 products
20Marketed7Unknown
Marketed
(empagliflozin + linagliptin + metformin hydrochloride) ER
Type 2 Diabetes
Marketed(empagliflozin + linagliptin)
Type 2 Diabetes
Marketed(empagliflozin + metformin hydrochloride ER)
Type 2 Diabetes
Marketed(linagliptin + metformin hydrochloride) ER
Type 2 Diabetes
Marketed(olodaterol hydrochloride + tiotropium bromide)
Chronic Bronchitis
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
no news has mentioned this company yet
comments(0)
5-min edit window · permanent after that